Neural Stem Cell-Derived Neurons
Cell therapyexperimental
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Feb 28, 2018 (NCT03309514)
Timeline
2010s
- Jan 1, 2018
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- NeuronsTissue restoration
tissue restoration - neurons
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03725865 | Early Phase 1 (Phase 1) | Mar 31, 2019 | Allife Medical Science and Technology Co., Ltd. |
| NCT03309514 | Phase 1/Phase 2 (Phase 2) | Feb 28, 2018 | NeuroGeneration |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Allife Medical Science and Technology Co., Ltd. | For profit | 1 | 1 | 1 | 2019 |
| NeuroGeneration | For profit | 1 | 1 | 1 | 2018 |
2 organizations
Page 1 / 1